UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 110,431 shares of the healthcare conglomerate’s stock after selling 10,195 shares during the quarter. UnitedHealth Group makes up approximately 0.7% of State of Alaska Department of Revenue’s portfolio, making the stock its 17th largest position. State of Alaska Department of Revenue’s holdings in UnitedHealth Group were worth $58,137,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Robbins Farley bought a new position in UnitedHealth Group during the third quarter worth $25,000. CGC Financial Services LLC increased its position in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL bought a new stake in UnitedHealth Group in the 1st quarter valued at $35,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Bank of America reissued a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. Truist Financial restated a “buy” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Thursday, November 30th. HSBC reiterated a “reduce” rating and set a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Finally, Barclays started coverage on shares of UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $579.33.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

NYSE UNH traded up $1.60 during trading hours on Friday, reaching $494.70. 3,820,008 shares of the company’s stock were exchanged, compared to its average volume of 4,274,309. The company’s 50-day moving average is $502.66 and its two-hundred day moving average is $518.44. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company has a market capitalization of $456.08 billion, a price-to-earnings ratio of 20.75, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.34 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.